复旦大学附属肿瘤医院乳腺外科主任邵志敏教授等人近期发表在《柳叶刀》上的《中国乳腺癌现状报告》显示,中国乳腺癌发病率年增幅速度是世界平均水平的2倍,照此推算,到2021年,中国乳腺癌患者将高迭250万。但多数患者没有及早确认所属亚型,丧失了个体化治疗机会。邵志敏指出,除早期预防、早期发现、早期治疗外,规范化综合治疗是提高乳腺癌治疗效果的最佳途径。随着分子生物学技 Professor Mao Shaomin, director of Department of Breast Surgery, Affiliated Tumor Hospital of Fudan University and others recently published in the “Lancet” report on the status of breast cancer in China, the incidence of breast cancer in China annual rate of increase is twice the world average, according to projections By 2021, China will have 2.5 million patients with breast cancer. However, most patients did not confirm their subtypes as soon as possible, thus losing the opportunity for individualized treatment. Shao Zhimin pointed out that, in addition to early prevention, early detection, early treatment, the standardization of comprehensive treatment is to improve the treatment of breast cancer the best way. With the molecular biology techniques